Similarly, elevating SOX2 in medulloblastoma cells, which causes a major reduction in their growth, leads to over a 10-fold increase in the number CD133+ cells just one day after elevating SOX2 [104]. The gene discussed is PROM1; the disease is medulloblastoma.